Endoscopy for Assessment of Mucosal Healing in IBD
Advanced Endoscopic Imaging Using HD+ Endoscopy and i-Scan for Assessment of Mucosal Healing in IBD
1 other identifier
observational
232
1 country
1
Brief Summary
Inflammatory bowel disease (IBD) encompasses two major forms of chronic intestinal disorders, Crohn's disease and ulcerative colitis (UC). Diagnosis is based on several macroscopic and histologic features including patterns of inflammation, crypt abscesses and granulomas. i-Scan use an endoscopic image from the video processor and reconstruct virtual images in real time, resulting in an improved contrast of the capillary patterns and enhancement of the mucosal surface (so called virtual chromoendoscopy). The main objective of this study is to determine endoscopic features of mucosal healing in patients with IBD and to compare these features to clinical and histological data in order to establish a new endoscopic classification of mucosal healing and to evaluate mucosal healing as a parameter of remission and relapse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 10, 2011
CompletedFirst Posted
Study publicly available on registry
August 16, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedDecember 14, 2020
December 1, 2020
2.8 years
August 10, 2011
December 10, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Mucosal healing
We will determine high-definition white light endoscopic and i-Scan features of mucosal inflammation (e.g. erosions, erythema, ulcerous lesions) in IBD in order to establish a new endoscopic classification of mucosal healing.
up to three years
Secondary Outcomes (2)
Histologic correlation
up to three years
Therapeutic effect
up to three years
Study Arms (4)
Crohn´s disease - active
Patients in the active phase of the disease
Crohn´s disease - quiescent
Patients in the quiescent phase of the disease
Ulcerative colitis - active
Patients in the active phase of the disease
Ucerative colitis - quiescent
Patients in the quiescent phase of the disease
Interventions
Patients will undergo advanced endoscopic imaging. Findings will be compared to histopathological and clinical results.
Eligibility Criteria
Patients with Crohn´s disease and ulcerative colitis were prospectively included.
You may qualify if:
- Written informed consent
- Age 18-85 years
- Ability of subjects to understand character and individual consequences of clinical trial
- Subjects undergoing colonoscopy
You may not qualify if:
- Inability to provide written informed consent
- Severe Coagulopathy (Prothrombin time \< 50% of control, Partial thromboplastin time \> 50 s)
- Pregnancy or breast feeding
- Active gastrointestinal bleeding
- Residing in institutions (e.g. prison)
- Proctocolectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Erlangen-Nuremberg
Erlangen, 91054, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Helmut Neumann, Professor
Department of Medicine I, University of Erlangen-Nuremberg, Germany
- PRINCIPAL INVESTIGATOR
Markus F. Neurath, Professor
Department of Medicine I, University of Erlangen-Nuremberg, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2011
First Posted
August 16, 2011
Study Start
August 1, 2011
Primary Completion
May 1, 2014
Study Completion
November 1, 2014
Last Updated
December 14, 2020
Record last verified: 2020-12